Nandita Shangari is a Board Observer, and Managing Director at the Novartis Venture Fund (NVF), a life science investment firm. Prior to joining NVF, she held various positions at Novartis in Business Development and Licensing and as a key member of the Kymriah® Global Program Team, helping to bring this novel cell therapy to market.Nandita also held strategic and group head roles in the Novartis Preclinical Investigative Toxicology organization. She received a B.Sc. in Biochemistry and a Ph.D. in Pharmaceutical Sciences from the University of Toronto, Canada
Nandita Shangari, PhD
Managing Director, Novartis Venture Fund, Board Observer
